28th Sep 2020 19:34
Open Orphan PLC - pharmaceutical services company - Wins GBP4.3 million contract to conduct human viral challenge study for unnamed vaccine firm. Trial is being conducted in quarantine unit in London, and contract is expected to be delivered in first quarter of 2021.
Current stock price: 18.60 pence
Year-to-date change: more than tripled from 5.03p
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ORPH.L